Abstract:Purpose of ReviewOver the past 2 decades, our understanding of the role of genetics in the development and progression of aortic disease has grown considerably. This review serves as a foundational text for the reader to gain a thorough understanding of the basics of this emerging field while also displaying the latest breakthroughs which have had, and will continue to have, important impacts on clinical decision-making and patient outcomes. This review focuses on aneurysmal disease, arguably the richest subgroup of aortic diseases for genetic research.Recent FindingsThoracic aortic aneurysm and dissection (TAAD) is driven primarily by genetic factors. Genetic variants which drive TAAD tend to occur in genes involved in the structure and function of the aortic wall, specifically the extracellular matrix, TGF-β pathway, and smooth muscle cell contractile units. At least 37 gene variants (pathological or of unknown significance) have been found to be directly associated with the development of TAAD, independent of traditional cardiovascular (CV) risk factors such as smoking and hypertension. The standard suggestion for definitive treatment is prophylactic surgery at an aortic diameter of 5.0–5.5 cm, but several gene variants have been shown to dissect commonly at much smaller diameters (such as TGFβR1/2 or ACTA2), and so mutation-specific guidelines are leading to earlier surgery and better patient outcomes in these aggressive cases.Abdominal aortic aneurysms (AAAs) also have a genetic component, but these are primarily driven by CV risk factors. Many gene variants have been found which are closely associated with these risk factors, such as those in the lipid metabolism pathway (SORT1). Four variants have been found through GWAS studies to directly influence AAAs independent of general risk factors, though the clinical implications are yet unclear.SummaryNew variants are discovered every year, and each creates a new avenue of research. As more data is collected on patients with each variant, such as the rate of growth, mode of inheritance, age at dissection, and diameter at dissection, we can craft more patient-specific guidelines for different subgroups of affected individuals, with the aim of achieving better long-term survival.

Understanding genomic medicine for thoracic aortic disease through the lens of induced pluripotent stem cells

Using Genomics to Identify Novel Therapeutic Targets for Aortic Disease

Human-induced Pluripotent Stem Cells As Models for Rare Cardiovascular Diseases: from Evidence-Based Medicine to Precision Medicine

Genetics and mechanisms of thoracic aortic disease

Development and Assessment of a Point-of-Care Application (Genomic Medicine Guidance) for Heritable Thoracic Aortic Disease

Modeling Aortic Diseases Using Induced Pluripotent Stem Cells

Genetic aortopathies: a case-based approach to multidisciplinary program development

Modeling Thoracic Aortic Dissection Using Patient-Specific iPSCs Reveals VSMC Dysfunction and Extracellular Matrix Dysregulation

Current state and future directions of genomic medicine in aortic dissection: A path to prevention and personalized care

Polygenic Scoring for Detection of Ascending Thoracic Aortic Dilation

Leveraging genetic data to improve the care of patients with thoracic aortic dilation

Therapeutics Targeting Drivers of Thoracic Aortic Aneurysms and Acute Aortic Dissections: Insights from Predisposing Genes and Mouse Models

Heritable thoracic aortic disease: a literature review on genetic aortopathies and current surgical management

Clinical effectiveness of genetic testing guidelines in patients with thoracic aortic aneurysms

Clinical Interpretation of Genetic Variants in the Evaluation and Management of Thoracic Aortic Aneurysm and Dissection

The Genetics of Inheritable Aortic Diseases

Molecular Mechanisms in Genetic Aortopathy-Signaling Pathways and Potential Interventions

Molecular Characterization and Clinical Investigation of Patients with Heritable Thoracic Aortic Aneurysm and Dissection.

Non‐syndromic thoracic aortic aneurysm: cellular and molecular insights

Toward Precision Medicine in Aortopathies: Genetic Insights from a Brazilian Cohort Through Targeted Next-Generation Sequencing

Advancements in Omics and Breakthrough Gene Therapies: A Glimpse into the Future of Peripheral Artery Disease